A detailed history of Stifel Financial Corp transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 10,942 shares of CSBR stock, worth $51,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,942
Previous 11,192 2.23%
Holding current value
$51,646
Previous $54,000 3.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.5 - $5.23 $1,125 - $1,307
-250 Reduced 2.23%
10,942 $56,000
Q1 2024

May 13, 2024

BUY
$4.9 - $6.91 $54,840 - $77,336
11,192 New
11,192 $54,000
Q3 2023

Nov 13, 2023

SELL
$5.2 - $7.32 $39,707 - $55,895
-7,636 Reduced 42.24%
10,442 $64,000
Q2 2023

Aug 14, 2023

SELL
$4.11 - $6.81 $17,455 - $28,922
-4,247 Reduced 19.02%
18,078 $115,000
Q1 2023

May 12, 2023

BUY
$4.0 - $4.67 $89,300 - $104,257
22,325 New
22,325 $89,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $63.8M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.